Manufacturers/Janssen Biotech, Inc.

Janssen Biotech, Inc.

10 drugs in NADAC|0 Generic,10 Brand

Total Drugs

0G / 10B

Avg Price / Unit

$13114.3492

$87.63 – $29841.65

Avg 7d Change

0.00%

Across 0 drugs with changes

7d Activity

10 flat

of 10 total drugs

Monthly average NADAC price across all drugs

10 drugs total, 10 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
STELARA 45 MG/0.5 ML SYRINGE ustekinumab	57894006003	$29841.6480 per ML	—	Brand	—	Interleukin-12 Antagonist, Interleukin-23 Antagonist
STELARA 90 MG/ML SYRINGE ustekinumab	57894006103	$29794.5447 per ML	—	Brand	—	Interleukin-12 Antagonist, Interleukin-23 Antagonist
TREMFYA 100 MG/ML SYRINGE Guselkumab	57894064001	$14769.7353 per ML	—	Brand	—	Interleukin-23 Antagonist
TREMFYA 100 MG/ML ONE-PRESS Guselkumab	57894064011	$14766.3280 per ML	—	Brand	—	Interleukin-23 Antagonist
SIMPONI 50 MG/0.5 ML SYRINGE golimumab	57894007001	$12977.2440 per ML	—	Brand	—	Tumor Necrosis Factor Blocker
SIMPONI 50 MG/0.5 ML PEN INJEC golimumab	57894007002	$12974.5178 per ML	—	Brand	—	Tumor Necrosis Factor Blocker
SIMPONI 100 MG/ML PEN INJECTOR golimumab	57894007102	$7446.2126 per ML	—	Brand	—	Tumor Necrosis Factor Blocker
TREMFYA 200 MG/2 ML PEN guselkumab	57894065102	$7349.6703 per ML	—	Brand	—	Interleukin-23 Antagonist
REMICADE 100 MG VIAL INFLIXIMAB	57894003001	$1135.9660 per EA	—	Brand	—	Tumor Necrosis Factor Blocker
ZYTIGA 250 MG TABLET abiraterone acetate	57894015012	$87.6254 per EA	—	Brand	High Outlier	Cytochrome P450 17A1 Inhibitor